Tau protein isoforms, phosphorylation and role in neurodegenerative disorders 1 1 These authors contributed equally to this work.

Tau proteins belong to the family of microtubule-associated proteins. They are mainly expressed in neurons where they play an important role in the assembly of tubulin monomers into microtubules to constitute the neuronal microtubules network. Microtubules are involved in maintaining the cell shape and serve as tracks for axonal transport. Tau proteins also establish some links between microtubules and other cytoskeletal elements or proteins. Tau proteins are translated from a single gene located on chromosome 17. Their expression is developmentally regulated by an alternative splicing mechanism and six different isoforms exist in the human adult brain. Tau proteins are the major constituents of intraneuronal and glial fibrillar lesions described in Alzheimer's disease and numerous neurodegenerative disorders referred to as 'tauopathies'. Molecular analysis has revealed that an abnormal phosphorylation might be one of the important events in the process leading to their aggregation. Moreover, a specific set of pathological tau proteins exhibiting a typical biochemical pattern, and a different regional and laminar distribution could characterize each of these disorders. Finally, a direct correlation has been established between the progressive involvement of the neocortical areas and the increasing severity of dementia, suggesting that pathological tau proteins are reliable marker of the neurodegenerative process. The recent discovery of tau gene mutations in frontotemporal dementia with parkinsonism linked to chromosome 17 has reinforced the predominant role attributed to tau proteins in the pathogenesis of neurodegenerative disorders, and underlined the fact that distinct sets of tau isoforms expressed in different neuronal populations could lead to different pathologies.

[1]  M. Goedert,et al.  Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. , 1995, The EMBO journal.

[2]  D. Geschwind,et al.  Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[3]  I Litvan,et al.  The clinical and pathologic hallmarks of progressive supranuclear palsy. , 1997, Current opinion in neurology.

[4]  H. Wiśniewski,et al.  Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. , 1986, The Journal of biological chemistry.

[5]  R. Rosenthal,et al.  Prevention of Postischemic Canine Neurological Injury Through Potentiation of Brain Energy Metabolism by Acetyl‐L‐Carnitine , 1992, Stroke.

[6]  P. Heutink,et al.  Hereditary frontotemporal dementia is linked to chromosome 17q21—q22: A genetic and clinicopathological study of three dutch families , 1997, Annals of neurology.

[7]  Hitoshi Takahashi,et al.  Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy , 1998, Acta Neuropathologica.

[8]  P. Hof,et al.  Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick’s disease , 1996, Acta Neuropathologica.

[9]  M. Goedert,et al.  Protein Phosphatase 2A Is the Major Enzyme in Brain that Dephosphorylates τ Protein Phosphorylated by Proline‐Directed Protein Kinases or Cyclic AMP‐Dependent Protein Kinase , 1995 .

[10]  Y. Yoshizawa,et al.  A Clinical Study of 36 Cases of Anaphylactoid Purpura: Comparison of Pediatric and Adolescent Cases to Adult Cases , 2000 .

[11]  W. Klein,et al.  Phosphorylated Tau Epitope of Alzheimer's Disease Is Coupled to Axon Development in the Avian Central Nervous System , 1993, Experimental Neurology.

[12]  P. Cohen,et al.  Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. , 1994, The Biochemical journal.

[13]  E. Mandelkow,et al.  Abnormal Alzheimer‐like phosphorylation of tau‐protein by cyclin‐dependent kinases cdk2 and cdk5 , 1993, FEBS letters.

[14]  N. Hirokawa,et al.  Selective stabilization of tau in axons and microtubule-associated protein 2C in cell bodies and dendrites contributes to polarized localization of cytoskeletal proteins in mature neurons , 1996, The Journal of cell biology.

[15]  G. Hart,et al.  The Microtubule-associated Protein Tau Is Extensively Modified with O-linked N-acetylglucosamine* , 1996, The Journal of Biological Chemistry.

[16]  M. Kirschner,et al.  Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. , 1977, Journal of molecular biology.

[17]  R. Shin Interaction of aluminum with paired helical filament tau is involved in neurofibrillary pathology of Alzheimer's disease. , 1997, Gerontology.

[18]  S. Feinstein,et al.  Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau , 1994, The Journal of cell biology.

[19]  A. Delacourte,et al.  Alzheimer-specific epitope of AT100 in transfected cell lines with tau: toward an efficient cell model of tau abnormal phosphorylation , 1998, Neuroscience Letters.

[20]  D. Galasko,et al.  Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease , 1997, Neurology.

[21]  J. Michalski,et al.  Effect of okadaic acid on O-linked N-acetylglucosamine levels in a neuroblastoma cell line. , 1999, Biochimica et biophysica acta.

[22]  A. Delacourte,et al.  Specific tau variants in the brains of patients with myotonic dystrophy , 1996, Neurology.

[23]  J. Gulcher,et al.  Molecular Evolution of τ Protein: Implications for Alzheimer's Disease , 1996 .

[24]  B. Hyman,et al.  Alz-50 immunoreactivity in the neonatal rat: Changes in development and co-distribution with MAP-2 immunoreactivity , 1989, Neuroscience Letters.

[25]  C. W. Scott,et al.  Casein kinase II preferentially phosphorylates human tau isoforms containing an amino-terminal insert. Identification of threonine 39 as the primary phosphate acceptor. , 1994, The Journal of biological chemistry.

[26]  Y. Agid,et al.  Dementia in Parkinson's disease: Biochemical evidence for cortical involvement using the immunodetection of abnormal tau proteins , 1993, Annals of neurology.

[27]  A. Delacourte,et al.  Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their τ isoform distribution and phosphorylation , 1998, Annals of neurology.

[28]  D. Dickson,et al.  Neuropathologic Overlap of Progressive Supranuclear Palsy, Pick's Disease and Corticobasal Degeneration , 1996, Journal of neuropathology and experimental neurology.

[29]  R. Brandt,et al.  Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain , 1995, The Journal of cell biology.

[30]  N. Cairns,et al.  Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated. , 1991, The Biochemical journal.

[31]  Lars Lannfelt,et al.  Increased cerebrospinal fluid tau in patients with Alzheimer's disease , 1995, Neuroscience Letters.

[32]  M. Novák Truncated tau protein as a new marker for Alzheimer's disease. , 1994, Acta virologica.

[33]  E. Vanmechelen,et al.  Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205 , 1995, Neuroscience Letters.

[34]  K. Fukunaga,et al.  Dephosphorylation of Microtubule Proteins by Brain Protein Phosphatases 1 and 2A, and Its Effect on Microtubule Assembly , 1988, Journal of neurochemistry.

[35]  L. Kurland,et al.  THE FINE STRUCTURE OF SOME INTRAGANGLIONIC ALTERATIONS , 1968 .

[36]  Y. Ihara,et al.  τ Is Widely Expressed in Rat Tissues , 1996 .

[37]  S. Mirra,et al.  FILAMENTOUS AGGREGATES IN PICK'S DISEASE, PROGRESSIVE SUPRANUCLEAR PALSY, AND ALZHEIMER'S DISEASE SHARE ANTIGENIC DETERMINANTS WITH MICROTUBULE-ASSOCIATED PROTEIN, TAU , 1986, The Lancet.

[38]  M. Goedert,et al.  Pick’s disease: hyperphosphorylated tau protein segregates to the somatoaxonal compartment , 1996, Acta Neuropathologica.

[39]  M. Reivich,et al.  ACTIVATION , 1980, The Social Value of Zoos.

[40]  D. Graham,et al.  Cerebral ischemia induces alterations in tau and ubiquitin proteins. , 1994, Dementia.

[41]  P. Reyes,et al.  Olfactory-related changes in Alzheimer's disease: A quantitative neuropathologic study , 1993, Brain Research Bulletin.

[42]  Douglas Galasko,et al.  The τ Protein in Human Cerebrospinal Fluid in Alzheimer's Disease Consists of Proteolytically Derived Fragments , 1997, Journal of neurochemistry.

[43]  G. Jicha,et al.  A Conformation‐ and Phosphorylation‐Dependent Antibody Recognizing the Paired Helical Filaments of Alzheimer's Disease , 1997, Journal of neurochemistry.

[44]  S. Yen,et al.  Characterization of In Vitro Glycation Sites of Tau , 1997, Journal of neurochemistry.

[45]  A. Hyman,et al.  Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. , 1992, Molecular biology of the cell.

[46]  S. Papasozomenos,et al.  The heat shock-induced hyperphosphorylation of tau is estrogen-independent and prevented by androgens: implications for Alzheimer disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[47]  G. Bloom,et al.  A novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell cycle , 1995, The Journal of cell biology.

[48]  R. Kisilevsky,et al.  Sulfated glycosaminoglycans in Alzheimer's disease. , 1987, Human pathology.

[49]  R. Crowther,et al.  Cloning and sequencing of the cDNA encoding an isoform of microtubule‐associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. , 1989, The EMBO journal.

[50]  D. Shackelford,et al.  Changes in Phosphorylation of τ During Ischemia and Reperfusion in the Rabbit Spinal Cord , 1996, Journal of neurochemistry.

[51]  M. Hasegawa,et al.  Dephosphorylation of fetal-tau and paired helical filaments-tau by protein phosphatases 1 and 2A and calcineurin. , 1995, Journal of biochemistry.

[52]  B. Ghetti,et al.  Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17: A New Group of Tauopathies , 1998, Brain pathology.

[53]  R. Marconi,et al.  The tau gene in progressive supranuclear palsy: exclusion of mutations in coding exons and exon 10 splice sites, and identification of a new intronic variant of the disease-associated H1 haplotype in Italian cases , 1999, Neuroscience Letters.

[54]  T. Chase,et al.  Topographic investigation of brain atrophy in parkinsonism-dementia complex of Guam: a comparison with Alzheimer's disease and progressive supranuclear palsy. , 1994, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[55]  J. Morrison,et al.  Neurochemical phenotype of corticocortical connections in the macaque monkey: Quantitative analysis of a subset of neurofilament protein‐immunoreactive projection neurons in frontal, parietal, temporal, and cingulate cortices , 1995, The Journal of comparative neurology.

[56]  N L Foster,et al.  Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference , 1997, Annals of neurology.

[57]  C. Duyckaerts,et al.  Modeling the Relation Between Neurofibrillary Tangles and Intellectual Status , 1997, Neurobiology of Aging.

[58]  I Litvan,et al.  Progressive supranuclear palsy and corticobasal degeneration. , 2011 .

[59]  A. Delacourte,et al.  Rapid Tau Protein Dephosphorylation and Differential Rephosphorylation during Cardiac Arrest-Induced Cerebral Ischemia and Reperfusion , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[60]  G. Drewes,et al.  Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer‐like state. , 1992, The EMBO journal.

[61]  John M. Lee,et al.  Reduction of Calcineurin Enzymatic Activity in Alzheimer's Disease: Correlation with Neuropathologic Changes , 1996, Journal of neuropathology and experimental neurology.

[62]  J. Morrison,et al.  Neurofibrillary tangle densities in the hippocampal formation in a non-demented population define subgroups of patients with differential early pathologic changes , 1993, Neuroscience Letters.

[63]  K S Kosik,et al.  MAP2 and tau segregate into dendritic and axonal domains after the elaboration of morphologically distinct neurites: an immunocytochemical study of cultured rat cerebrum , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[64]  J. Trojanowski,et al.  Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: focusing on phosphatases , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[65]  C. Duyckaerts,et al.  Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer's disease and aging , 1990, Neuroscience Letters.

[66]  K. Urakami,et al.  Tau proteins in cerebrospinal fluid from patients with Alzheimer's disease: a longitudinal study. , 1996, Dementia.

[67]  Y. Ihara,et al.  Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease. , 1986, Journal of biochemistry.

[68]  J. Trojanowski,et al.  Tau Proteins Are Abnormally Expressed in Olfactory Epithelium of Alzheimer Patients and Developmentally Regulated in Human Fetal Spinal Cord , 1993, Experimental Neurology.

[69]  J. Ávila,et al.  τ Protein from Alzheimer's Disease Patients Is Glycated at Its Tubulin‐Binding Domain , 1995, Journal of neurochemistry.

[70]  S. Hirai,et al.  Tau in cerebrospinal fluids: establishment of the sandwich ELISA with antibody specific to the repeat sequence in tau , 1995, Neuroscience Letters.

[71]  R. Neve,et al.  Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2. , 1986, Brain research.

[72]  A. Grover,et al.  5′ Splice Site Mutations in tau Associated with the Inherited Dementia FTDP-17 Affect a Stem-Loop Structure That Regulates Alternative Splicing of Exon 10* , 1999, The Journal of Biological Chemistry.

[73]  K. Blennow,et al.  Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer’s disease: a community based follow up study , 1998, Journal of neurology, neurosurgery, and psychiatry.

[74]  M. Tabaton,et al.  Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy , 2000, Annals of neurology.

[75]  M G Spillantini,et al.  Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. , 1999, Journal of neuropathology and experimental neurology.

[76]  A. Delacourte,et al.  Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases , 1997, FEBS letters.

[77]  L. Binder,et al.  Rapid reversible phosphorylation of rat brain tau proteins in response to cold water stress , 1995, Neuroscience Letters.

[78]  G. Schellenberg,et al.  Tau is a candidate gene for chromosome 17 frontotemporal dementia , 1998, Annals of neurology.

[79]  J. Ávila,et al.  Role of glycosaminoglycans in determining the helicity of paired helical filaments. , 1997, The American journal of pathology.

[80]  M. Kirschner,et al.  Tau protein binds to microtubules through a flexible array of distributed weak sites , 1991, The Journal of cell biology.

[81]  W. Pavan,et al.  Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. , 1997, Science.

[82]  C. Duijn,et al.  High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. , 1999, American journal of human genetics.

[83]  J. Morrison,et al.  Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital. , 1994, Cerebral cortex.

[84]  M. Kirschner,et al.  Tau protein function in living cells , 1986, The Journal of cell biology.

[85]  John X. Morris,et al.  Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. , 1998, Science.

[86]  H. S. Yin,et al.  Changes in the microtubule proteins in the developing and transected spinal cords of the bullforg tadpole: Induction of microtubule-associated protein 2c and enhanced levels of Tau and tubulin in regenerating central axons , 1995, Neuroscience.

[87]  E. Mandelkow,et al.  RNA stimulates aggregation of microtubule‐associated protein tau into Alzheimer‐like paired helical filaments , 1996, FEBS letters.

[88]  A. Kurz,et al.  Cerebrospinal protein tau is elevated in early Alzheimer's disease , 1996, Neuroscience Letters.

[89]  I. Correas,et al.  The tubulin-binding sequence of brain microtubule-associated proteins, tau and MAP-2, is also involved in actin binding. , 1990, The Biochemical journal.

[90]  D. Dickson,et al.  Tau gene mutation in familial progressive subcortical gliosis , 1999, Nature Medicine.

[91]  A. Delacourte,et al.  Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments , 1986, Journal of the Neurological Sciences.

[92]  J. Goldman,et al.  Glial Inclusions in CNS Degenerative Diseases , 1996, Journal of neuropathology and experimental neurology.

[93]  Daniel L. Koller,et al.  Familial multiple-system tauopathy with presenile dementia is localized to chromosome 17. , 1997, American journal of human genetics.

[94]  G. Johnson,et al.  Modulation of tau phosphorylation and intracellular localization by cellular stress. , 2000, The Biochemical journal.

[95]  A. Matus Stiff microtubules and neuronal morphology , 1994, Trends in Neurosciences.

[96]  M. Goedert,et al.  Tau proteins with FTDP‐17 mutations have a reduced ability to promote microtubule assembly , 1998, FEBS letters.

[97]  G. Johnson,et al.  Phosphorylation by cAMP-dependent protein kinase inhibits the degradation of tau by calpain. , 1992, The Journal of biological chemistry.

[98]  L. Michalik,et al.  Expression of specific tau exons in normal and tumoral pancreatic acinar cells. , 1998, Journal of cell science.

[99]  H. Braak,et al.  Demonstration of Amyloid Deposits and Neurofibrillary Changes in Whole Brain Sections , 1991, Brain pathology.

[100]  S. Busby,et al.  O-glycosylation of nuclear and cytoplasmic proteins: regulation analogous to phosphorylation? , 1997, Biochemical and biophysical research communications.

[101]  A. Sawa,et al.  Molecular diversity at the carboxyl terminus of human and rat tau. , 1994, Brain research. Molecular brain research.

[102]  M. Kirschner,et al.  A protein factor essential for microtubule assembly. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[103]  K. Titani,et al.  Proline-directed and Non-proline-directed Phosphorylation of PHF-tau (*) , 1995, The Journal of Biological Chemistry.

[104]  E. Mandelkow,et al.  Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding , 1993, Neuron.

[105]  N. Cairns,et al.  Tau proteins of alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms , 1992, Neuron.

[106]  M. Albert,et al.  The `subcortical dementia' of progressive supranuclear palsy , 1974, Journal of neurology, neurosurgery, and psychiatry.

[107]  G. Johnson Differential Phosphorylation of τ by Cyclic AMP‐Dependent Protein Kinase and Ca2+/Calmodulin‐Dependent Protein Kinase II: Metabolic and Functional Consequences , 1992 .

[108]  S. Hirai,et al.  Longitudinal study of cerebrospinal fluid levels of tau, Aβ1–40, and Aβ1–42(43) in Alzheimer's disease: A study in Japan , 1998 .

[109]  H. Wiśniewski,et al.  Ultrastructure of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome. , 1973, Archives of neurology.

[110]  D. Selkoe,et al.  Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[111]  L. Kurland,et al.  Amyotrophic lateral sclerosis and Parkinsonism-dementia complex on Guam. Further pathologic studies. , 1966, Archives of neurology.

[112]  D. Brautigan,et al.  Protein Phosphatase 1 Is Targeted to Microtubules by the Microtubule-associated Protein Tau* , 1998, The Journal of Biological Chemistry.

[113]  J. Woodgett,et al.  PHF‐tau from Alzheimer's brain comprises four species on SDS‐PAGE which can be mimicked by in vitro phosphorylation of human brain tau by glycogen synthase kinase‐3β , 1994, FEBS letters.

[114]  J. Morrison,et al.  Neurofibrillary tangle distribution in the cerebral cortex of parkinsonism-dementia cases from Guam: differences with Alzheimer's disease , 1991, Brain Research.

[115]  J. Trojanowski,et al.  Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques , 1997, Annals of neurology.

[116]  A. Frankfurter,et al.  The distribution of tau in the mammalian central nervous system , 1985, The Journal of cell biology.

[117]  L. Gustafson,et al.  Clinical picture of frontal lobe degeneration of non-Alzheimer type. , 1993, Dementia.

[118]  D. Dickson,et al.  Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration. , 1994, The American journal of pathology.

[119]  N. Robakis,et al.  Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide , 1993, Brain Research.

[120]  J. Hardy,et al.  Neurodegenerative diseases of Guam: Analysis of TAU , 1999, Neurology.

[121]  S. Lovestone,et al.  The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes. , 1997, Neuroscience.

[122]  R. Nixon,et al.  Neurofilament phosphorylation: a new look at regulation and function , 1991, Trends in Neurosciences.

[123]  P. Cohen,et al.  Protein phosphatases: properties and role in cellular regulation. , 1983, Science.

[124]  K. Fukunaga,et al.  Dephosphorylation of Microtubule‐Associated Protein 2, τ Factor, and Tubulin by Calcineurin , 1985, Journal of neurochemistry.

[125]  M. Kirschner,et al.  Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains , 1989, Molecular and cellular biology.

[126]  C. Geula Pathological Diagnosis of Alzheimer’s Disease , 2000 .

[127]  Hideyuki Yamamoto,et al.  Dephosphorylation of abnormal sites of tau factor by protein phosphatases and its implication for Alzheimer's disease , 1995, Neurochemistry International.

[128]  R. Garruto Pacific paradigms of environmentally-induced neurological disorders: clinical, epidemiological and molecular perspectives. , 1991, Neurotoxicology.

[129]  E. Mandelkow,et al.  Domains of tau protein and interactions with microtubules. , 1994, Biochemistry.

[130]  A. Delacourte,et al.  The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease , 1999, Neurology.

[131]  Kevin Cox,et al.  Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex , 1990, The Journal of comparative neurology.

[132]  J. Trojanowski,et al.  Detection of Phosphorylated Ser262 in Fetal Tau, Adult Tau, and Paired Helical Filament Tau (*) , 1995, The Journal of Biological Chemistry.

[133]  G. Johnson,et al.  Transglutaminase cross-linking of the tau protein. , 1995, Journal of neurochemistry.

[134]  Jan Six,et al.  Detection of Proteins in Normal and Alzheimer's Disease Cerebrospinal Fluid with a Sensitive Sandwich Enzyme‐Linked Immunosorbent Assay , 1993 .

[135]  H. Geerts,et al.  Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. , 1999, The American journal of pathology.

[136]  J. Woodgett,et al.  Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase , 1992, Neuroscience Letters.

[137]  Wei Li,et al.  Heparin-induced Conformational Change in Microtubule-associated Protein Tau as Detected by Chemical Cross-linking and Phosphopeptide Mapping* , 1999, The Journal of Biological Chemistry.

[138]  E. Richardson,et al.  Corticodentatonigral degeneration with neuronal achromasia. , 1968, Archives of neurology.

[139]  P. Hof,et al.  Specific Pathological Tau Protein Variants Characterize Pick's Disease , 1996, Journal of neuropathology and experimental neurology.

[140]  W. Benzing,et al.  Apolipoprotein E immunoreactivity within neurofibrillary tangles: relationship to tau and PHF in Alzheimer's disease , 1995, Experimental Neurology.

[141]  S. Dudek,et al.  Transglutaminase Catalyzes the Formation of Sodium Dodecyl Sulfate‐Insoluble, Alz‐50‐Reactive Polymers of τ , 1993, Journal of neurochemistry.

[142]  A. Lang,et al.  Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration. , 1997, Journal of neuropathology and experimental neurology.

[143]  D. Housman,et al.  Expansion of a CUG trinucleotide repeat in the 3' untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[144]  S. Rhee,et al.  Activation of Phospholipase C-γ by the Concerted Action of Tau Proteins and Arachidonic Acid* , 1996, The Journal of Biological Chemistry.

[145]  Y. Agid,et al.  Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism. , 1998, Human molecular genetics.

[146]  S. Dudek,et al.  Postnatal changes in serine/threonine protein phosphatases and their association with the microtubules. , 1995, Brain research. Developmental brain research.

[147]  J. Trojanowski,et al.  The phosphorylation state of tau in the developing rat brain is regulated by phosphoprotein phosphatases. , 1994, The Journal of biological chemistry.

[148]  B. Anderton,et al.  Stress‐Activated Protein Kinase/c‐Jun N‐Terminal Kinase Phosphorylates τ Protein , 1997, Journal of neurochemistry.

[149]  E. Mandelkow,et al.  Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation. , 1998, European journal of biochemistry.

[150]  E. Sadot,et al.  Identification of a tau promoter region mediating tissue-specific-regulated expression in PC12 cells. , 1996, Journal of molecular biology.

[151]  J. Simon,et al.  The extra sex combs product contains WD40 repeats and its time of action implies a role distinct from other Polycomb group products , 1995, Mechanisms of Development.

[152]  D. F. Brown,et al.  Progressive supranuclear palsy with dementia: cortical pathology. , 1999, Journal of neuropathology and experimental neurology.

[153]  W. Kamphorst,et al.  Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau. , 1998, The American journal of pathology.

[154]  G. Johnson,et al.  Transglutaminase Cross‐Linking of the τ Protein , 1995 .

[155]  P. Hof,et al.  Apolipoprotein E in Guamanian amyotrophic lateral sclerosis/ parkinsonism-dementia complex: genotype analysis and relationships to neuropathological changes , 1996, Acta Neuropathologica.

[156]  G. Drewes,et al.  MARK, a Novel Family of Protein Kinases That Phosphorylate Microtubule-Associated Proteins and Trigger Microtubule Disruption , 1997, Cell.

[157]  J. Mandell,et al.  The microtubule cytoskeleton and the development of neuronal polarity , 1995, Neurobiology of Aging.

[158]  R. Liem,et al.  Expression of high molecular weight tau in the central and peripheral nervous systems. , 1993, Journal of cell science.

[159]  Kiyoharu Inoue,et al.  Neuropathological changes of the brain in myotonic dystrophy - some new observations , 1987, Journal of the Neurological Sciences.

[160]  J. Trojanowski,et al.  τ Phosphorylation in Human, Primate, and Rat Brain: Evidence that a Pool of τ Is Highly Phosphorylated In Vivo and Is Rapidly Dephosphorylated In Vitro , 1994, Journal of neurochemistry.

[161]  Z. Makita,et al.  Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. , 1998, The American journal of pathology.

[162]  D. Hanger,et al.  A68 proteins in Alzheimer's disease are composed of several tau isoforms in a phosphorylated state which affects their electrophoretic mobilities. , 1991, The Biochemical journal.

[163]  G. Johnson,et al.  Localization and in situ phosphorylation state of nuclear tau. , 1995, Experimental cell research.

[164]  B K Hayes,et al.  O-GlcNAcylation of key nuclear and cytoskeletal proteins: reciprocity with O-phosphorylation and putative roles in protein multimerization. , 1996, Glycobiology.

[165]  L. Yang,et al.  Calpain-induced proteolysis of normal human tau and tau associated with paired helical filaments. , 1995, European journal of biochemistry.

[166]  B. Schmitz,et al.  O-linked N-acetylglucosamine is upregulated in Alzheimer brains. , 1995, Biochemical and biophysical research communications.

[167]  P. Davies,et al.  Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. , 1992, The Journal of biological chemistry.

[168]  T. Wight,et al.  Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease. , 1995, Archives of biochemistry and biophysics.

[169]  R. Neve,et al.  The microtubule binding domain of tau protein , 1989, Neuron.

[170]  K. G. Coleman,et al.  Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. , 1997, Science.

[171]  N. Hirokawa,et al.  Projection domains of MAP2 and tau determine spacings between microtubules in dendrites and axons , 1992, Nature.

[172]  A. Delacourte,et al.  Dephosphorylation studies of SKNSH-SY 5Y cell Tau proteins by endogenous phosphatase activity , 1996, Neuroscience Letters.

[173]  K. Wilhelmsen,et al.  Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. , 1994, American journal of human genetics.

[174]  O. Lichtarge,et al.  The murine Polycomb-group gene eed and its human orthologue: functional implications of evolutionary conservation. , 1998, Genomics.

[175]  R. Braun,et al.  Proline-directed phosphorylation of human Tau protein. , 1992, The Journal of biological chemistry.

[176]  E. Mandelkow,et al.  Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[177]  H. Wiśniewski,et al.  Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[178]  Mark A. Smith,et al.  Quantitative solubilization and analysis of insoluble paired helical filaments from alzheimer disease , 1996, Brain Research.

[179]  R. A. Crowther,et al.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease , 1989, Neuron.

[180]  J. Gerstmann,et al.  Über eine eigenartige hereditär- familiäre Erkrankung des Zentralnervensystems , 1935 .

[181]  D. Jung,et al.  Interaction of microtubules and microtubule-associated proteins (MAPs) with rat brain mitochondria. , 1990, The Biochemical journal.

[182]  W. G. Kelly,et al.  Glycosylation of nuclear and cytoplasmic proteins is ubiquitous and dynamic. , 1992, Biochemical Society transactions.

[183]  M. Rossor,et al.  Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease , 1999, Neuroscience Letters.

[184]  S. Yen,et al.  Phosphate analysis and dephosphorylation of modified tau associated with paired helical filaments , 1992, Brain Research.

[185]  P. Hof,et al.  Pathological τ proteins in postencephalitic parkinsonism: Comparison with Alzheimer's disease and other neurodegenerative disorders , 1997 .

[186]  P. Hof,et al.  Distribution of neurofibrillary tangles and senile plaques in the cerebral cortex in postencephalitic parkinsonism , 1992, Neuroscience Letters.

[187]  R. Maccioni,et al.  DMAP‐85: A τ‐Like Protein from Drosophila melanogaster Larvae , 1995 .

[188]  M. Yamagishi,et al.  Pathology of Olfactory Mucosa in Patients with Alzheimer's Disease , 1994, The Annals of otology, rhinology, and laryngology.

[189]  L. Kurland,et al.  Parkinsonism-dementia complex, an endemic disease on the island of Guam. I. Clinical features. , 1961, Brain : a journal of neurology.

[190]  M. Kirschner,et al.  Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. , 1977, Journal of molecular biology.

[191]  D. Perl,et al.  Aluminum, Alzheimer's Disease, and the Olfactory System a , 1991, Annals of the New York Academy of Sciences.

[192]  G. Schellenberg,et al.  A distinct familial presenile dementia with a novel missense mutation in the tau gene. , 1999, Neuroreport.

[193]  J. Olszewski,et al.  Progressive Supranuclear Palsy: A Heterogeneous Degeneration Involving the Brain Stem, Basal Ganglia and Cerebellum With Vertical Gaze and Pseudobulbar Palsy, Nuchal Dystonia and Dementia , 1964 .

[194]  R. Marconi,et al.  Direct genetic evidence for involvement of tau in progressive supranuclear palsy , 1998, Neurology.

[195]  L. Forno,et al.  Neuropathology of Parkinson's Disease , 1996, Journal of neuropathology and experimental neurology.

[196]  Kenneth S. Kosik,et al.  Developmentally regulated expression of specific tau sequences , 1989, Neuron.

[197]  W. Gordon-Krajcer,et al.  Tau Released from Paired Helical Filaments with Formic Acid or Guanidine Is Susceptible to Calpain‐Mediated Proteolysis , 1997, Journal of neurochemistry.

[198]  J. Ávila,et al.  Polymerization of τ into Filaments in the Presence of Heparin: The Minimal Sequence Required for τ ‐ τ Interaction , 1996 .

[199]  I Litvan,et al.  Validity and Reliability of the Preliminary NINDS Neuropathologic Criteria for Progressive Supranuclear Palsy and Related Disorders , 1996, Journal of neuropathology and experimental neurology.

[200]  John A. Martin,et al.  Neurofibrillary Tangles in Progressive Supranuclear Palsy Contain the Same Tau Epitopes Identified in Alzheimer's Disease PHFtau , 1996, Journal of neuropathology and experimental neurology.

[201]  J. Molinuevo,et al.  Significant changes in the tau A0 and A3 alleles in progressive supranuclear palsy and improved genotyping by silver detection. , 1998, Archives of neurology.

[202]  P. Hof,et al.  Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins. , 1995, The American journal of pathology.

[203]  Y. Miyata,et al.  Binding of microtubule-associated protein 2 and tau to the intermediate filament reassembled from neurofilament 70-kDa subunit protein. Its regulation by calmodulin. , 1986, The Journal of biological chemistry.

[204]  P. Deyn,et al.  Improved discrimination of AD patients using β-amyloid(1-42) and tau levels in CSF , 1999, Neurology.

[205]  M. Mercken,et al.  Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[206]  S. Otsuki,et al.  Frequency of Alzheimer's neurofibrillary tangles in the cerebral cortex in progressive supranuclear palsy (subcortical argyrophilic dystrophy) , 1976, Journal of the Neurological Sciences.

[207]  M. Radeke,et al.  Functional interactions between the proline-rich and repeat regions of tau enhance microtubule binding and assembly. , 1997, Molecular biology of the cell.

[208]  R. Obar,et al.  Diverse distribution and function of fibrous microtubule-associated proteins in the nervous system. , 1994, International review of cytology.

[209]  G. Johnson,et al.  Modulation of the phosphorylation state of tau in situ: the roles of calcium and cyclic AMP. , 1995, The Biochemical journal.

[210]  Bin Zhang,et al.  Age-Dependent Emergence and Progression of a Tauopathy in Transgenic Mice Overexpressing the Shortest Human Tau Isoform , 1999, Neuron.

[211]  L. Chang,et al.  Tau protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's disease. , 1995, Annals of clinical and laboratory science.

[212]  I. Litvan,et al.  Progressive supranuclear gaze palsy is in linkage disequilibrium with theτ and not the α-synuclein gene , 1998, Neurology.

[213]  C. Miller,et al.  Human c-Jun N-terminal kinase expression and activation in the nervous system. , 1999, Brain research. Molecular brain research.

[214]  K. Marder,et al.  Clinical characteristics of a family with chromosome 17‐linked disinhibition‐dementia‐ parkinsonism‐amyotrophy complex , 1994, Neurology.

[215]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[216]  R. Crowther,et al.  Effects of frontotemporal dementia FTDP‐17 mutations on heparin‐induced assembly of tau filaments , 1999, FEBS letters.

[217]  J. McDermott,et al.  ptl-1, a Caenorhabditis elegans gene whose products are homologous to the tau microtubule-associated proteins. , 1996, Biochemistry.

[218]  M. Vandermeeren,et al.  Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. , 1993, Journal of neurochemistry.

[219]  W. Goux,et al.  Analysis of the core components of Alzheimer paired helical filaments A gas chromatography/mass spectrometry characterization of fatty acids, carbohydrates and long‐chain bases , 1995, FEBS letters.

[220]  J. Ahringer,et al.  PTL-1, a microtubule-associated protein with tau-like repeats from the nematode Caenorhabditis elegans. , 1996, Journal of cell science.

[221]  E. Miyamoto,et al.  In situ dephosphorylation of tau by protein phosphatase 2A and 2B in fetal rat primary cultured neurons , 1995, FEBS letters.

[222]  A. Delacourte,et al.  Two‐Dimensional Characterization of Paired Helical Filament‐Tau from Alzheimer's Disease: Demonstration of an Additional 74‐kDa Component and Age‐Related Biochemical Modifications , 1997, Journal of neurochemistry.

[223]  M. Guazzelli,et al.  Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits. , 1999, Journal of neuropathology and experimental neurology.

[224]  C. Hock,et al.  Histological Markers in Nasal Mucosa of Patients with Alzheimer’s Disease , 1998, European Neurology.

[225]  G. Pals,et al.  Localization of the gene for rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration to chromosome 17q21. , 1996, Human molecular genetics.

[226]  S. Yen,et al.  An immunochemical study on tau glycation in paired helical filaments , 1999, Brain Research.

[227]  J. Trojanowski,et al.  Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology. , 1997, Biochemical and biophysical research communications.

[228]  L. Lannfelt,et al.  Microtubule-associated protein tau in human fibroblasts with the Swedish Alzheimer mutation , 1996, Neuroscience Letters.

[229]  M. Kirschner,et al.  The primary structure and heterogeneity of tau protein from mouse brain. , 1988, Science.

[230]  H. Braak,et al.  Alzheimer’s disease: transiently developing dendritic changes in pyramidal cells of sector CA1 of the Ammon’s horn , 1997, Acta Neuropathologica.

[231]  J. Trojanowski,et al.  The Neuropathology of a Chromosome 17-Linked Autosomal Dominant Parkinsonism and Dementia (“Pallido-Ponto-Nigral Degeneration”) , 1998, Journal of neuropathology and experimental neurology.

[232]  J. Brook,et al.  Transcriptional abnormality in myotonic dystrophy affects DMPK but not neighboring genes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[233]  R. Williams,et al.  Microtubule-associated proteins connect microtubules and neurofilaments in vitro. , 1984, Biochemistry.

[234]  B. Ghetti,et al.  Prion Protein Amyloidosis , 1996, Brain pathology.

[235]  H. Kresse,et al.  Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid-containing plaques and their presence in neurofibrillary tangles of Alzheimer's disease. , 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[236]  Philip R. Cohen,et al.  Phosphorylation of microtubule‐associated protein tau by stress‐activated protein kinases , 1997, FEBS letters.

[237]  M. Rebhan,et al.  Complementary distribution of tau proteins in different phosphorylation states within growing axons. , 1995, Neuroreport.

[238]  J. Molinuevo,et al.  Identification of a novel polymorphism in the promoter region of the tau gene highly associated to progressive supranuclear palsy in humans , 1999, Neuroscience Letters.

[239]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[240]  G. Giaccone,et al.  Gerstmann‐Sträussler‐Scheinker Disease and the Indiana Kindred , 1995, Brain pathology.

[241]  P. Lantos,et al.  β‐Amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer’s disease , 1999 .

[242]  A. Himmler Structure of the bovine tau gene: alternatively spliced transcripts generate a protein family , 1989, Molecular and cellular biology.

[243]  G. Hart,et al.  Glycosylation of mammalian neurofilaments. Localization of multiple O-linked N-acetylglucosamine moieties on neurofilament polypeptides L and M. , 1993, The Journal of biological chemistry.

[244]  K. Kosik,et al.  Structure and novel exons of the human tau gene. , 1992, Biochemistry.

[245]  Panteleimon Giannakopoulos,et al.  Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts , 1997, Brain Research Reviews.

[246]  G. Lee,et al.  Expression of tau protein in non-neuronal cells: microtubule binding and stabilization. , 1992, Journal of cell science.

[247]  D. Dickson,et al.  Detection of a Cdc2-related kinase associated with Alzheimer paired helical filaments. , 1995, The American journal of pathology.

[248]  K. Kosik,et al.  A τ Promoter Region Without Neuronal Specificity , 1996 .

[249]  A. Delacourte,et al.  Presence of abnormally phosphorylated Tau proteins in the entorhinal cortex of aged non-demented subjects , 1992, Neuroscience Letters.

[250]  P. C. Murphy,et al.  Cerebral Cortex , 2017, Cerebral Cortex.

[251]  P. Davies,et al.  Mitotic mechanisms in Alzheimer's disease? , 1996, The Journal of cell biology.

[252]  P. Hof,et al.  Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration , 1999, Acta Neuropathologica.

[253]  J. Baudier,et al.  Phosphorylation of tau proteins to a state like that in Alzheimer's brain is catalyzed by a calcium/calmodulin-dependent kinase and modulated by phospholipids. , 1987, The Journal of biological chemistry.

[254]  Virginia M. Y. Lee,et al.  Recognition of the minimal epitope of monoclonal antibody Tau‐1 depends upon the presence of a phosphate group but not its location , 1993, Journal of neuroscience research.

[255]  K. Blennow,et al.  Combination of the different biological markers for increasing specificity of in vivo Alzheimer's testing. , 1998, Journal of neural transmission. Supplementum.

[256]  A. Hofman,et al.  Frequency and distribution of Alzheimer's disease in Europe: A collaborative study of 1980–1990 prevalence findings , 1991, Annals of neurology.

[257]  D. Perl,et al.  Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. , 1980, Science.

[258]  J. Troncoso,et al.  Transglutaminase‐Induced Cross‐Linking of Tau Proteins in Progressive Supranuclear Palsy , 2000, Journal of neuropathology and experimental neurology.

[259]  K. Blennow,et al.  A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[260]  D. Dewar,et al.  Tau protein is altered by focal cerebral ischaemia in the rat: an immunohistochemical and immunoblotting study , 1995, Brain Research.

[261]  G. Hart,et al.  Erythrocytes contain cytoplasmic glycoproteins. O-linked GlcNAc on Band 4.1. , 1987, The Journal of biological chemistry.

[262]  P. Cohen,et al.  Protein phosphatases come of age. , 1989, The Journal of biological chemistry.

[263]  G. V. Van Hoesen,et al.  The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. , 1991, Cerebral cortex.

[264]  K. Mehta,et al.  Tissue transglutaminase: an enzyme with a split personality. , 1999, The international journal of biochemistry & cell biology.

[265]  A. Delacourte,et al.  Neurofibrillary Degeneration in Progressive Supranuclear Palsy and Corticobasal Degeneration , 1999, Journal of neurochemistry.

[266]  M. Goedert,et al.  Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. , 1990, The EMBO journal.

[267]  K. Blennow,et al.  Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample. , 1999, Neurology.

[268]  K. Blennow,et al.  Cerebrospinal fluid tau and Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment , 1999, Neuroscience Letters.

[269]  T. Arendt,et al.  Abnormally phosphorylated tau protein in Alzheimer's disease: Heterogeneity of individual regional distribution and relationship to clinical severity , 1994, Neuroscience.

[270]  I. Irminger-Finger,et al.  Analysis of the primary sequence and microtubule-binding region of the Drosophila 205K MAP , 1990, The Journal of cell biology.

[271]  S. Brion,et al.  Maladie de Pick. Point de vue anatomo-clinique. , 1991 .

[272]  A. Delacourte,et al.  Induction of a specific tau Alzheimer epitope in SY‐5Y neuroblastoma cells , 1996, Neuroreport.

[273]  John Q. Trojanowski,et al.  Abnormal tau phosphorylation at Ser396 in alzheimer's disease recapitulates development and contributes to reduced microtubule binding , 1993, Neuron.

[274]  J. Trojanowski,et al.  Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's disease , 1995, Annals of neurology.

[275]  A J Lees,et al.  Familial progressive supranuclear palsy. Description of a pedigree and review of the literature. , 1995, Brain : a journal of neurology.

[276]  S. Stamm,et al.  Complex Regulation of Tau Exon 10, Whose Missplicing Causes Frontotemporal Dementia , 2000, Journal of neurochemistry.

[277]  D W Dickson,et al.  Widespread cytoskeletal pathology characterizes corticobasal degeneration. , 1995, The American journal of pathology.

[278]  D. Sparks,et al.  Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease. , 1995, Archives of neurology.

[279]  S. Jenkins,et al.  Tau complexes with phospholipase C‐γ in situ , 1998 .

[280]  I Litvan,et al.  Association of an extended haplotype in the tau gene with progressive supranuclear palsy. , 1999, Human molecular genetics.

[281]  D. Wilson,et al.  Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease. , 1997, The American journal of pathology.

[282]  M. Ding,et al.  High Molecular Weight Microtubule-associated Proteins Contain O-Linked N-Acetylglucosamine (*) , 1996, Journal of Biological Chemistry.

[283]  L. Pradel,et al.  Interaction between microtubule-associated protein tau and spectrin. , 1984, Biochimie.

[284]  G. Banker,et al.  The expression and distribution of the microtubule-associated proteins tau and microtubule-associated protein 2 in hippocampal neurons in the rat in situ and in cell culture , 1987, Neuroscience.

[285]  M. Saraste,et al.  FEBS Lett , 2000 .

[286]  C. Bruton,et al.  The aftermath of boxing , 1973, Psychological Medicine.

[287]  Yasuo Ihara,et al.  Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments , 1993, Neuron.

[288]  R. Brandt,et al.  The Balance Between τ Protein's Microtubule Growth and Nucleation Activities: Implications for the Formation of Axonal Microtubules , 1993, Journal of neurochemistry.

[289]  A J Lees,et al.  Pathological overlap in cases of parkinsonism associated with neurofibrillary tangles. A study of recent cases of postencephalitic parkinsonism and comparison with progressive supranuclear palsy and Guamanian parkinsonism-dementia complex. , 1993, Brain : a journal of neurology.

[290]  C. Miller,et al.  p493F12 kinase: A novel MAP kinase expressed in a subset of neurons in the human nervous system , 1995, Neuron.

[291]  A. Delacourte,et al.  Comparative Biochemistry of Tau in Progressive Supranuclear Palsy, Corticobasal Degeneration, FTDP‐17 and Pick's Disease , 1999, Brain pathology.

[292]  N. Hirokawa,et al.  Altered microtubule organization in small-calibre axons of mice lacking tau protein , 1994, Nature.

[293]  J. Trojanowski,et al.  Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[294]  S. Love,et al.  Neurofibrillary tangles in Niemann-Pick disease type C. , 1995, Brain : a journal of neurology.

[295]  R. Zinkowski,et al.  Presence of tau in isolated nuclei from human brain , 1995, Neurobiology of Aging.

[296]  G. Jicha,et al.  Hierarchical Phosphorylation of Recombinant Tau by the Paired‐Helical Filament‐Associated Protein Kinase Is Dependent on Cyclic AMP‐Dependent Protein Kinase , 1999, Journal of neurochemistry.

[297]  Hitoshi Takahashi,et al.  NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease , 1997, Neuroscience Letters.

[298]  M. Tolnay,et al.  REVIEW: tau protein pathology in Alzheimer’s disease and related disorders , 1999, Neuropathology and applied neurobiology.

[299]  I Litvan,et al.  Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.

[300]  S. M. Sumi,et al.  Chromosome 17 and hereditary dementia , 1997, Neurology.

[301]  W. Pilcher,et al.  Low Initial Tau Phosphorylation in Human Brain Biopsy Samples , 1997, Neurobiology of Aging.

[302]  E. Otomo,et al.  Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease , 1991, Brain Research.

[303]  A. Ferreira,et al.  Microtubule formation and neurite growth in cerebellar macroneurons which develop in vitro: evidence for the involvement of the microtubule-associated proteins, MAP-1a, HMW-MAP2 and Tau. , 1989, Brain research. Developmental brain research.

[304]  S. Love,et al.  Microtubule-associated protein tau, heparan sulphate and α-synuclein in several neurodegenerative diseases with dementia , 1999, Acta Neuropathologica.

[305]  T. Tabira,et al.  FTDP‐17 mutations N279K and S305N in tau produce increased splicing of exon 10 , 1999, FEBS letters.

[306]  S. Feinstein,et al.  Kinetic stabilization of microtubule dynamics at steady state by tau and microtubule-binding domains of tau. , 1995, Biochemistry.

[307]  A. Delacourte,et al.  Neurofibrillary tangles in Gerstmann-Sträussler-Scheinker syndrome with the A117V prion gene mutation , 1997, Journal of neurology, neurosurgery, and psychiatry.

[308]  K. Kosik,et al.  Along the way to a neurofibrillary tangle: a look at the structure of tau. , 1989, Annals of medicine.

[309]  G. Bloom,et al.  Molecular Interactions among Protein Phosphatase 2A, Tau, and Microtubules , 1999, The Journal of Biological Chemistry.

[310]  J. Morrison,et al.  Cortical Neuropathology in Aging and Dementing Disorders , 1999 .

[311]  D. Mann,et al.  AN ANALYSIS OF THE MORPHOLOGY OF SENILE PLAQUES IN DOWN'S SYNDROME PATIENTS OF DIFFERENT AGES USING IMMUNOCYTOCHEMICAL AND LECTIN HISTOCHEMICAL TECHNIQUES , 1989, Neuropathology and applied neurobiology.

[312]  D. Vandré,et al.  Alzheimer's Disease Neurofibrillary Tangles Contain Mitosis‐Specific Phosphoepitopes , 1996, Journal of neurochemistry.

[313]  G. Lindwall,et al.  Phosphorylation affects the ability of tau protein to promote microtubule assembly. , 1984, The Journal of biological chemistry.

[314]  H. Band,et al.  Tau interacts with src-family non-receptor tyrosine kinases. , 1998, Journal of cell science.

[315]  M G Spillantini,et al.  Alpha-synuclein in Lewy bodies. , 1997, Nature.

[316]  I. Allen,et al.  Association of measles virus with neurofibrillary tangles in subacute sclerosing panencephalitis: a combined in situ hybridization and immunocytochemical investigation , 1994, Neuropathology and applied neurobiology.

[317]  A. Kurz,et al.  Tau Protein in Cerebrospinal Fluid Is Significantly Increased at the Earliest Clinical Stage of Alzheimer Disease , 1998, Alzheimer disease and associated disorders.

[318]  A. Delacourte,et al.  AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease. , 1996, Brain research. Molecular brain research.

[319]  G. Drewes,et al.  Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro , 1992, The Journal of cell biology.

[320]  Y. Ihara,et al.  Ubiquitin is a component of paired helical filaments in Alzheimer's disease. , 1987, Science.

[321]  K. Kosik,et al.  Relative exon affinities and suboptimal splice site signals lead to non-equivalence of two cassette exons. , 1995, Nucleic acids research.

[322]  Giovanni B. Frisoni,et al.  Consensus report of the working group on: 'Molecular and biochemical markers of Alzheimer's disease' , 1998 .

[323]  K. Blennow,et al.  Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? , 1995, Molecular and chemical neuropathology.

[324]  M. Pericak-Vance,et al.  Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[325]  J. Poirier,et al.  Apolipoprotein E, synaptic plasticity and Alzheimer's disease. , 1995, Annals of medicine.

[326]  D. Benson,et al.  Subcortical Dementia: Review of an Emerging Concept , 1984 .

[327]  W. Goux,et al.  Characterization of the Glycolipid Associated with Alzheimer Paired Helical Filaments , 1996, Journal of neurochemistry.

[328]  John S. Kauer,et al.  Pathological changes in olfactory neurons in patients with Alzheimer's disease , 1989, Nature.

[329]  D. Appelt,et al.  The association of tissue transglutaminase with human recombinant tau results in the formation of insoluble filamentous structures , 1997, Brain Research.

[330]  A. Delacourte,et al.  Phosphorylation of Tau proteins: a major event during the process of neurofibrillary degeneration. A comparative study between Alzheimer's disease and Down's syndrome , 1990, Brain Research.

[331]  C. Hock,et al.  Increased levels of τ protein in cerebrospinal fluid of patients with alzheimer's disease—correlation with degree of cognitive impairment , 1995, Annals of neurology.

[332]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[333]  B. Riederer,et al.  Differential distribution of tau proteins in developing cat cerebellum , 1994, Brain Research Bulletin.

[334]  I. Grundke‐Iqbal,et al.  Glycosylation of microtubule–associated protein tau: An abnormal posttranslational modification in Alzheimer's disease , 1996, Nature Medicine.

[335]  L. Thal,et al.  Genetic evidence for the involvement of τ in progressive supranuclear palsy , 1997, Annals of neurology.

[336]  J. Brion,et al.  Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease. , 1999, The American journal of pathology.

[337]  T D Pollard,et al.  Phosphorylation of microtubule-associated proteins regulates their interaction with actin filaments. , 1983, The Journal of biological chemistry.

[338]  G. Perry,et al.  Advanced Maillard reaction end products are associated with Alzheimer disease pathology. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[339]  J. Trojanowski,et al.  Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau , 1994, Neuron.

[340]  T D Pollard,et al.  The interaction of actin filaments with microtubules and microtubule-associated proteins. , 1982, The Journal of biological chemistry.

[341]  K. Jellinger,et al.  On the relationship between measles virus and Alzheimer neurofibrillary tangles in subacute sclerosing panencephalitis , 1996, Neurobiology of Aging.

[342]  A. Delacourte,et al.  Isoelectric point differentiates PHF-tau from biopsy-derived human brain tau proteins. , 1995, Neuroreport.

[343]  J. Kuret,et al.  Tau Is Modified by Tissue Transglutaminase In Situ: Possible Functional and Metabolic Effects of Polyamination , 1999, Journal of neurochemistry.

[344]  M. Rebhan,et al.  Developmental expression of tau proteins in the chicken and rat brain: Rapid down-regulation of a paired helical filament epitope in the rat cerebral cortex coincides with the transition from immature to adult tau isoforms , 1995, International Journal of Developmental Neuroscience.

[345]  I. Litvan,et al.  A lack of the R406W tau mutation in progressive supranuclear palsy and corticobasal degeneration , 1999, Neurology.

[346]  A Klug,et al.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[347]  L Carlin,et al.  Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. , 1995, Archives of neurology.

[348]  R. Crowther,et al.  Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans , 1996, Nature.

[349]  G. Hart,et al.  Dynamic Glycosylation of Nuclear and Cytosolic Proteins , 1997, The Journal of Biological Chemistry.

[350]  P. Jong,et al.  Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy , 1992, Nature.

[351]  Y. Ihara,et al.  Tau is widely expressed in rat tissues. , 1996, Journal of neurochemistry.

[352]  C D Marsden,et al.  Corticobasal degeneration: A clinical study of 36 cases , 1994 .

[353]  Alistair Burns,et al.  Observations on the brains of demented old people. B.E. Tomlinson, G. Blessed and M. Roth, Journal of the Neurological Sciences (1970) 11, 205–242; (1968) 7, 331–356 , 1997 .

[354]  M. Rossor,et al.  The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases , 1999, Journal of neurology, neurosurgery, and psychiatry.

[355]  A. Delacourte,et al.  Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes , 1998, FEBS letters.

[356]  G. Schellenberg,et al.  Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[357]  M. Kidd Paired Helical Filaments in Electron Microscopy of Alzheimer's Disease , 1963, Nature.

[358]  A. Bailey,et al.  Evidence for glucose-mediated covalent cross-linking of collagen after glycosylation in vitro. , 1985, The Biochemical journal.

[359]  A. Delacourte,et al.  Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide , 1993, Brain Research.

[360]  K. Imahori,et al.  Involvement of τ Protein Kinase I in Paired Helical Filament‐Like Phosphorylation of the Juvenile τ in Rat Brain , 1995 .

[361]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[362]  J. Kauer,et al.  Pathologic Changes in Olfactory Neurons in Alzheimer's Disease a , 1991, Annals of the New York Academy of Sciences.

[363]  E. Mandelkow,et al.  Overexpression of Tau Protein Inhibits Kinesin-dependent Trafficking of Vesicles, Mitochondria, and Endoplasmic Reticulum: Implications for Alzheimer's Disease , 1998, The Journal of cell biology.

[364]  R. Sattilaro,et al.  Microtubule-associated proteins (MAPs) and the organization of actin filaments in vitro , 1981, The Journal of cell biology.

[365]  P. Yates,et al.  ALZHEIMER'S PRESENILE DEMENTIA, SENILE DEMENTIA OF ALZHEIMER TYPE AND DOWN'S SYNDROME IN MIDDLE AGE FORM AN AGE RELATED CONTINUUM OF PATHOLOGICAL CHANGES , 1984, Neuropathology and applied neurobiology.

[366]  J. Zweier,et al.  Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide , 1995, Nature Medicine.

[367]  I. Grundke‐Iqbal,et al.  Phosphatase Activity Toward Abnormally Phosphorylated τ: Decrease in Alzheimer Disease Brain , 1995, Journal of neurochemistry.

[368]  N. Hirokawa,et al.  Tau Proteins: the Molecular Structure and Mode of Binding on Microtubules Materials and Methods Isolation of Tau , 1988 .

[369]  R. Liem,et al.  Interactions between neurofilaments and microtubule-associated proteins: a possible mechanism for intraorganellar bridging , 1982, The Journal of cell biology.

[370]  S. Papasozomenos Heat Shock Induces Rapid Dephosphorylation of τ in Both Female and Male Rats Followed by Hyperphosphorylation Only in Female Rats: Implications for Alzheimer's Disease , 1996, Journal of neurochemistry.

[371]  R. Maccioni,et al.  Subpopulations of tau interact with microtubules and actin filaments in various cell types , 1995, Cell biochemistry and function.

[372]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[373]  Olivier Rascol,et al.  A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy , 1999, Acta Neuropathologica.

[374]  R. Tucker,et al.  The roles of microtubule-associated proteins in brain morphogenesis: a review , 1990, Brain Research Reviews.

[375]  K. Titani,et al.  Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain. , 1992, The Journal of biological chemistry.

[376]  M. Hutton,et al.  Fibrillogenesis of Tau: Insights from Tau Missense Mutations in FTDP‐17 , 1999, Brain pathology.

[377]  A. Defossez,et al.  Démonstration directe d'une phosphorylation anormale des protéines microtubulaires Tau au cours de la maladie d'Alzheimer , 1989 .

[378]  E. Tolosa,et al.  Significant association between the tau gene A0/A0 genotype and Parkinson's disease , 2000, Annals of neurology.

[379]  J. Brion,et al.  Neurofibrillary tangles of Alzheimer's disease: an immunohistochemical study. , 1985, Journal of submicroscopic cytology.

[380]  John M. Lee,et al.  Elevated transglutaminase-induced bonds in PHF tau in Alzheimer's disease , 1999, Brain Research.

[381]  H. Wiśniewski,et al.  Neuropathological diagnosis of Alzheimer disease. , 1989, Journal of neuropathology and experimental neurology.

[382]  C. W. Scott,et al.  Aggregation of tau protein by aluminum , 1993, Brain Research.

[383]  R. Wolfert,et al.  Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease , 1995 .

[384]  R. Crowther,et al.  Characterization of mAb AP422, a novel phosphorylation‐dependent monoclonal antibody against tau protein , 1996 .

[385]  H. Roder,et al.  Phosphorylation-dependent Monoclonal Tau Antibodies Do Not Reliably Report Phosphorylation by Extracellular Signal-regulated Kinase 2 at Specific Sites* , 1997, The Journal of Biological Chemistry.

[386]  J. Trojanowski,et al.  A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. , 1991, Science.

[387]  A. Delacourte,et al.  Normal and pathological Tau proteins as factors for microtubule assembly. , 1997, International review of cytology.

[388]  Patrick Vermersch,et al.  Cortical mapping of Alzheimer pathology in brains of aged non-demented subjects , 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[389]  G. Hart,et al.  c-Myc Is Glycosylated at Threonine 58, a Known Phosphorylation Site and a Mutational Hot Spot in Lymphomas (*) , 1995, The Journal of Biological Chemistry.